Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
Schizophrenia is a chronic mental illness with a poor quality of life (QoL). The main aim of this study was to measure the QoL and factors that affect the QoL of patients with schizophrenia placed in a social welfare institution. This cross-sectional study included 287 patients with schizophrenia who were treated in a long-stay social care institution in which QoL was assessed using five different instruments: the World Health Organization Quality of Life scale, the EuroQoL Five-Dimension-Five-Level scale (including the visual analog scale), the Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form, and the Brief Psychiatric Rating Scale. To determine the impact of patients’ characteristics on score values, multiple linear regression using backward elimination was employed. Due to non-normality in the distribution of the dependent variables, a Box–Cox power transformation was applied to each dependent variable prior to conducting multiple linear regression analysis. Results revealed that patients with schizophrenia have lower QoL. Our study revealed that age, level of education, type of accommodation, type of pavilion, age of onset of the disease, number of prescribed antipsychotics, number of psychiatric comorbidities, duration of therapy, and the number of daily doses of antipsychotics are dominant contributors to the QoL in patients with schizophrenia who were treated in social welfare institution..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Open Medicine - 19(2024), 1, Seite 201-10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Petrovic Aleksandra D. [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Medicine |
|---|
| doi: |
10.1515/med-2024-0947 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ092529275 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ092529275 | ||
| 003 | DE-627 | ||
| 005 | 20240412125716.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/med-2024-0947 |2 doi | |
| 035 | |a (DE-627)DOAJ092529275 | ||
| 035 | |a (DE-599)DOAJcd05f170da0847e0a25dd97064fbebfc | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Petrovic Aleksandra D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Schizophrenia is a chronic mental illness with a poor quality of life (QoL). The main aim of this study was to measure the QoL and factors that affect the QoL of patients with schizophrenia placed in a social welfare institution. This cross-sectional study included 287 patients with schizophrenia who were treated in a long-stay social care institution in which QoL was assessed using five different instruments: the World Health Organization Quality of Life scale, the EuroQoL Five-Dimension-Five-Level scale (including the visual analog scale), the Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form, and the Brief Psychiatric Rating Scale. To determine the impact of patients’ characteristics on score values, multiple linear regression using backward elimination was employed. Due to non-normality in the distribution of the dependent variables, a Box–Cox power transformation was applied to each dependent variable prior to conducting multiple linear regression analysis. Results revealed that patients with schizophrenia have lower QoL. Our study revealed that age, level of education, type of accommodation, type of pavilion, age of onset of the disease, number of prescribed antipsychotics, number of psychiatric comorbidities, duration of therapy, and the number of daily doses of antipsychotics are dominant contributors to the QoL in patients with schizophrenia who were treated in social welfare institution. | ||
| 650 | 4 | |a quality of life | |
| 650 | 4 | |a schizophrenia | |
| 650 | 4 | |a questionnaires | |
| 650 | 4 | |a social welfare institution | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Barjaktarevic Ana M. |e verfasserin |4 aut | |
| 700 | 0 | |a Kostic Olivera Z. |e verfasserin |4 aut | |
| 700 | 0 | |a Dimitrijevic Jelena M. |e verfasserin |4 aut | |
| 700 | 0 | |a Mijailovic Sara S. |e verfasserin |4 aut | |
| 700 | 0 | |a Gogic Andjela D. |e verfasserin |4 aut | |
| 700 | 0 | |a Jankovic Slobodan M. |e verfasserin |4 aut | |
| 700 | 0 | |a Andjelkovic Marija V. |e verfasserin |4 aut | |
| 700 | 0 | |a Stanojevic Pirkovic Marijana S. |e verfasserin |4 aut | |
| 700 | 0 | |a Parezanovic Ilic Katarina D. |e verfasserin |4 aut | |
| 700 | 0 | |a Kostic Marina J. |e verfasserin |4 aut | |
| 700 | 0 | |a Janjic Vladimir S. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Open Medicine |d De Gruyter, 2015 |g 19(2024), 1, Seite 201-10 |w (DE-627)DOAJ000118591 |x 23915463 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g pages:201-10 |
| 856 | 4 | 0 | |u https://doi.org/10.1515/med-2024-0947 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/cd05f170da0847e0a25dd97064fbebfc |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1515/med-2024-0947 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2391-5463 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 1 |h 201-10 | ||